Rebecca Vanlandingham
About Rebecca Vanlandingham
Rebecca Vanlandingham is the Clinical Development Lead for ICN/Immunology/Dermatology at Bristol Myers Squibb, with over two decades of experience in clinical development and patient care.
Current Position at Bristol Myers Squibb
Rebecca Vanlandingham currently serves as the Clinical Development Lead for ICN/Immunology/Dermatology at Bristol Myers Squibb. She is responsible for overseeing clinical development processes and contributing to advancements in treatments for immunological and dermatological conditions.
Past Role at Eidos Therapeutics
From 2020 to 2022, Rebecca Vanlandingham held the position of Senior Director of Clinical Development at Eidos Therapeutics in the San Francisco Bay Area. In this role, she played a significant part in the clinical development initiatives that contributed to the growth and success of the company.
Leadership at Teva Pharmaceuticals
Rebecca Vanlandingham has an extensive history with Teva Pharmaceuticals, where she held various leadership roles in clinical development. She was promoted from Associate Director (2016-2018) to Director (2018-2020) in the Greater Philadelphia Area, showcasing her expertise and dedication to the field.
Academic Background in Immunology and Dermatology
Rebecca Vanlandingham has a robust academic background, specializing in immunology and dermatology. She completed an Allergy/Immunology Fellowship at Duke University (2000-2003), a Pediatric Residency at Children's Hospital of Michigan through Wayne State University (1997-2000), and obtained her M.D. from Washington University School of Medicine in St. Louis (1993-1997). She also holds a B.S. with High Honors in Biology from the University of Michigan (1988-1992).
Clinical Experience in Allergist/Immunologist Roles
Rebecca Vanlandingham has extensive experience as an Allergist/Immunologist, working in various capacities including at The Breathmobile of Northern California (2010-2013), Rebecca G. Piltch, M.D., Inc. (2008-2016), and The Permanente Medical Group (2003-2005 as Associate Physician, and 2006-2016 as Pool Physician). She has a strong focus on providing care to underserved communities and has been committed to improving patient outcomes across her roles.
Committee Involvement in Medical Field
Rebecca Vanlandingham has shown a long-standing commitment to the medical community by serving as a Committee Member from 1994 to 2016. Her involvement spanned over two decades, reflecting her dedication to the advancement and governance of medical practices and standards.